155 related articles for article (PubMed ID: 7762708)
1. The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes.
Garrard J; Chen V; Dowd B
Am J Public Health; 1995 Jun; 85(6):771-6. PubMed ID: 7762708
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations.
Garrard J; Makris L; Dunham T; Heston LL; Cooper S; Ratner ER; Zelterman D; Kane RL
JAMA; 1991 Jan 23-30; 265(4):463-7. PubMed ID: 1670645
[TBL] [Abstract][Full Text] [Related]
3. The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes.
Rovner BW; Edelman BA; Cox MP; Shmuely Y
Am J Psychiatry; 1992 Oct; 149(10):1390-2. PubMed ID: 1530076
[TBL] [Abstract][Full Text] [Related]
4. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations.
Shorr RI; Fought RL; Ray WA
JAMA; 1994 Feb; 271(5):358-62. PubMed ID: 8283585
[TBL] [Abstract][Full Text] [Related]
5. The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities.
Borson S; Doane K
Psychiatr Serv; 1997 Oct; 48(10):1289-96. PubMed ID: 9323748
[TBL] [Abstract][Full Text] [Related]
6. Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education.
Ray WA; Taylor JA; Meador KG; Lichtenstein MJ; Griffin MR; Fought R; Adams ML; Blazer DG
Arch Intern Med; 1993 Mar; 153(6):713-21. PubMed ID: 8447709
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic use in community residential care facilities: A prospective cohort study.
Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
[TBL] [Abstract][Full Text] [Related]
8. Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been?
Hughes CM; Lapane KL
Drugs Aging; 2005; 22(4):339-51. PubMed ID: 15839722
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts.
Richter T; Mann E; Meyer G; Haastert B; Köpke S
J Am Med Dir Assoc; 2012 Feb; 13(2):187.e7-187.e13. PubMed ID: 21549645
[TBL] [Abstract][Full Text] [Related]
10. Reducing Psychotropic Drug Use in Nursing Homes in Belgium: An Implementation Study for the Roll-Out of a Practice Improvement Initiative.
Wauters M; Elseviers M; Peeters L; De Meester D; Christiaens T; Petrovic M
Drugs Aging; 2019 Aug; 36(8):769-780. PubMed ID: 31209735
[TBL] [Abstract][Full Text] [Related]
11. Effects of a restraint reduction intervention and OBRA '87 regulations on psychoactive drug use in nursing homes.
Siegler EL; Capezuti E; Maislin G; Baumgarten M; Evans L; Strumpf N
J Am Geriatr Soc; 1997 Jul; 45(7):791-6. PubMed ID: 9215327
[TBL] [Abstract][Full Text] [Related]
12. A ten-year review of the effect of OBRA-87 on psychotropic prescribing practices in an academic nursing home.
Lantz MS; Giambanco V; Buchalter EN
Psychiatr Serv; 1996 Sep; 47(9):951-5. PubMed ID: 8875659
[TBL] [Abstract][Full Text] [Related]
13. Appropriate use of psychotropic drugs in nursing homes.
Gurvich T; Cunningham JA
Am Fam Physician; 2000 Mar; 61(5):1437-46. PubMed ID: 10735348
[TBL] [Abstract][Full Text] [Related]
14. Dementia and use of psychotropic medication in non-'Elderly Mentally Infirm' nursing homes in South East England.
Macdonald AJ; Carpenter GI; Box O; Roberts A; Sahu S
Age Ageing; 2002 Jan; 31(1):58-64. PubMed ID: 11850309
[TBL] [Abstract][Full Text] [Related]
15. The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective.
Hughes CM; Lapane KL; Mor V; Ikegami N; Jónsson PV; Ljunggren G; Sgadari A
J Am Geriatr Soc; 2000 Aug; 48(8):931-7. PubMed ID: 10968297
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.
Jacquin-Piques A; Sacco G; Tavassoli N; Rouaud O; Bejot Y; Giroud M; Robert P; Vellas B; Bonin-Guillaume S
J Alzheimers Dis; 2016; 49(3):671-80. PubMed ID: 26484903
[TBL] [Abstract][Full Text] [Related]
17. Eight-Year Trends in the Use of Opioids, Other Analgesics, and Psychotropic Medications Among Institutionalized Older People in Finland.
Pitkala KH; Juola AL; Hosia H; Teramura-Gronblad M; Soini H; Savikko N; Bell JS
J Am Med Dir Assoc; 2015 Nov; 16(11):973-8. PubMed ID: 26170037
[TBL] [Abstract][Full Text] [Related]
18. Psychotropic drug prescriptions in Western European nursing homes.
Janus SI; van Manen JG; IJzerman MJ; Zuidema SU
Int Psychogeriatr; 2016 Nov; 28(11):1775-1790. PubMed ID: 27469071
[TBL] [Abstract][Full Text] [Related]
19. Psychotropic drug prescriptions for nursing home residents.
Burns BJ; Kamerow DB
J Fam Pract; 1988 Feb; 26(2):155-60. PubMed ID: 3339319
[TBL] [Abstract][Full Text] [Related]
20. Unintended impacts of a national antipsychotic reduction initiative among nursing facility residents with and without Alzheimer's disease.
Wastila L; Qato DM; Fleming S; Johnson A; Briesacher B; McArdle PF; Holmes S; Lucas JA; Desai A; Brandt N; Zarowitz B
J Am Geriatr Soc; 2023 Jun; 71(6):1714-1723. PubMed ID: 36840533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
